Home › Compare › MGCLF vs YUM

MGCLF vs YUM: Dividend Comparison 2026

MGCLF yields 747.66% · YUM yields 1.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MGCLF wins by $1570996.11M in total portfolio value
10 years
MGCLF
MGCLF
● Live price
747.66%
Share price
$0.27
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1570996.21M
Annual income
$1,243,755,946,498.34
Full MGCLF calculator →
YUM
YUM
● Live price
1.86%
Share price
$154.59
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.9K
Annual income
$40,443.52
Full YUM calculator →

Portfolio growth — MGCLF vs YUM

📍 MGCLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGCLFYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGCLF + YUM cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MGCLF pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGCLF
Annual income on $10K today (after 15% tax)
$63,551.40/yr
After 10yr DRIP, annual income (after tax)
$1,057,192,554,523.59/yr
YUM
Annual income on $10K today (after 15% tax)
$158.35/yr
After 10yr DRIP, annual income (after tax)
$34,376.99/yr
At 15% tax rate, MGCLF beats the other by $1,057,192,520,146.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGCLF + YUM for your $10,000?

MGCLF: 50%YUM: 50%
100% YUM50/50100% MGCLF
Portfolio after 10yr
$785498.16M
Annual income
$621,877,993,470.93/yr
Blended yield
79.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

MGCLF
No analyst data
Altman Z
-16.1
Piotroski
2/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+12.0% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGCLF buys
0
YUM buys
0
No recent congressional trades found for MGCLF or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGCLFYUM
Forward yield747.66% ✓1.86%
Annual dividend / share$2.00$2.88 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4% ✓
Portfolio after 10y$1570996.21M ✓$107.9K
Annual income after 10y$1,243,755,946,498.34 ✓$40,443.52
Total dividends collected$1544814.76M ✓$81.2K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: MGCLF vs YUM ($10,000, DRIP)

YearMGCLF PortfolioMGCLF Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$85,466$74,766.36$10,982$282.06+$74.5K → MGCLF
2$688,646$597,197.00$12,189$438.29+$676.5K → MGCLF
3$5,233,973$4,497,122.12$13,731$688.32+$5.22M → MGCLF
4$37,544,137$31,943,785.57$15,789$1,097.12+$37.53M → MGCLF
5$254,319,833$214,147,606.64$18,679$1,785.08+$254.30M → MGCLF
6$1,627,834,568$1,355,712,346.12$22,975$2,988.18+$1627.81M → MGCLF
7$9,851,651,442$8,109,868,455.03$29,784$5,200.49+$9851.62M → MGCLF
8$56,411,273,720$45,870,006,676.23$41,408$9,539.16+$56411.23M → MGCLF
9$305,832,024,786$245,471,961,906.33$63,071$18,765.27+$305831.96M → MGCLF
10$1,570,996,213,020$1,243,755,946,498.34$107,930$40,443.52+$1570996.11M → MGCLF

MGCLF vs YUM: Complete Analysis 2026

MGCLF — Stock

MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.

Full MGCLF Calculator →

YUM — Consumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this MGCLF vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGCLF vs SCHDMGCLF vs JEPIMGCLF vs OMGCLF vs KOMGCLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.